Vigilant Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-11,321
| Closed | -$2.08M | – | 824 |
|
|
2021
Q2 | $2.08M | Sell |
11,321
-26,274
| -70% | -$4.83M | 0.17% | 55 |
|
|
2021
Q1 | $5.75M | Sell |
37,595
-54,308
| -59% | -$8.3M | 0.51% | 48 |
|
|
2020
Q4 | $14.4M | Buy |
91,903
+446
| +0.5% | +$69.7K | 1.38% | 39 |
|
|
2020
Q3 | $10.5M | Buy |
91,457
+752
| +0.8% | +$86K | 1.15% | 41 |
|
|
2020
Q2 | $10.2M | Buy |
90,705
+1,153
| +1% | +$129K | 1.24% | 39 |
|
|
2020
Q1 | $8.04M | Sell |
89,552
-17,903
| -17% | -$1.61M | 1.17% | 41 |
|
|
2019
Q4 | $11.6M | Sell |
107,455
-10,120
| -9% | -$1.09M | 1.35% | 41 |
|
|
2019
Q3 | $11.5M | Buy |
117,575
+3,746
| +3% | +$367K | 1.5% | 40 |
|
|
2019
Q2 | $14.9M | Buy |
113,829
+4,467
| +4% | +$585K | 1.99% | 23 |
|
|
2019
Q1 | $14.8M | Buy |
109,362
+2,749
| +3% | +$372K | 2.06% | 20 |
|
|
2018
Q4 | $10.4M | Sell |
106,613
-1,107
| -1% | -$108K | 1.65% | 35 |
|
|
2018
Q3 | $15M | Buy |
107,720
+21,180
| +24% | +$2.94M | 2% | 17 |
|
|
2018
Q2 | $10.7M | Buy |
+86,540
| New | +$10.7M | 1.56% | 35 |
|
|
2016
Q3 | – | Sell |
-150
| Closed | -$18K | – | 385 |
|
|
2016
Q2 | $18K | Buy |
+150
| New | +$18K | ﹤0.01% | 243 |
|